ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
M. Crespo F. Bosch N. Villamar ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia N Engl J Med 348 2003 1764
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation: Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation
A. Gratwohl J. Hermans J.M. Goldman Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation Lancet 352 1998 1087
E.S. Jaffe N.L. Harris H. Stein World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues 2001 IARC Press Lyon
(2001)
5
4444288930
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine
U. Jehn R. Bortl H. Dietzfelbinger An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine Leukemia 18 9 2004 1476
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy
M.J. Keating S. O’Brien S. Lerner Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy Blood 92 1998 1165
Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics
R. Kurzrock H.M. Kantarjian B.J. Druker Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics Ann Intern Med 138 2003 319
Imatinib compared with interferon and low-dose cytarabine for newly-diagnosed chronic-phase chronic myeloid leukemia
S.G. O’Brien F. Guilhot R.A. Larson Imatinib compared with interferon and low-dose cytarabine for newly-diagnosed chronic-phase chronic myeloid leukemia N Engl J Med 348 2003 994